Home > News > Investing in nano: venture capitalists tell their side of the story
March 7th, 2005
Investing in nano: venture capitalists tell their side of the story
Micro and nanotech have many supporters, yet few put their money where their mouth is quite like venture capitalists. Four veteran VCs recently took a break from doling out dollars, and put their due diligence to work on a few questions posed by Jeff Karoub. They are Mark Brandt, managing partner of the Maple Fund, Jeff Fagnan, partner at Atlas Venture, Matthew McCall, partner at Portage Venture Partners, and Waqar Qureshi, vice president at Chevron-Texaco Technology Ventures' Molecular-Diamond Technologies.
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015